Christopher R King

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint Health-related quality of life after stereotactic body radiation therapy for localized prostate cancer: results from a multi-institutional consortium of prospective trials
    Christopher R King
    Department of Radiation Oncology, University of California, Los Angeles, California Electronic address
    Int J Radiat Oncol Biol Phys 87:939-45. 2013
  2. doi request reprint Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials
    Christopher R King
    Department of Radiation Oncology, UCLA, Los Angeles, CA Electronic address
    Radiother Oncol 109:217-21. 2013
  3. doi request reprint Adjuvant versus salvage radiotherapy for high-risk prostate cancer patients
    Christopher R King
    Department of Radiation Oncology, University of California, Los Angeles, CA 90095, USA
    Semin Radiat Oncol 23:215-21. 2013
  4. doi request reprint The timing of salvage radiotherapy after radical prostatectomy: a systematic review
    Christopher R King
    Department of Radiation Oncology, UCLA School of Medicine, Los Angeles, California 90095, USA
    Int J Radiat Oncol Biol Phys 84:104-11. 2012
  5. doi request reprint Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer
    Christopher R King
    Departments of Radiation Oncology, University of California Los Angeles School of Medicine, Los Angeles, CA 90095, USA
    Int J Radiat Oncol Biol Phys 82:877-82. 2012
  6. pmc Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes
    Debra E Freeman
    Naples Radiation Oncology, PA, USA
    Radiat Oncol 6:3. 2011
  7. ncbi request reprint Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database
    Christopher R King
    Division of Urologic Oncology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305 5847, USA
    Urology 69:921-6. 2007
  8. ncbi request reprint Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial
    Christopher R King
    Department of Radiation Oncology, Division of Urologic Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 73:1043-8. 2009
  9. ncbi request reprint Obesity and risk of biochemical failure for patients receiving salvage radiotherapy after prostatectomy
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305 5847, USA
    Int J Radiat Oncol Biol Phys 73:1017-22. 2009
  10. doi request reprint Prognostic significance of prostate cancer originating from the transition zone
    Christopher R King
    Department of Radiation Oncology, Division of Urologic Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Urol Oncol 27:592-7. 2009

Collaborators

Detail Information

Publications31

  1. doi request reprint Health-related quality of life after stereotactic body radiation therapy for localized prostate cancer: results from a multi-institutional consortium of prospective trials
    Christopher R King
    Department of Radiation Oncology, University of California, Los Angeles, California Electronic address
    Int J Radiat Oncol Biol Phys 87:939-45. 2013
    ..To evaluate the early and late health-related quality of life (QOL) outcomes among prostate cancer patients following stereotactic body radiation therapy (SBRT)...
  2. doi request reprint Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials
    Christopher R King
    Department of Radiation Oncology, UCLA, Los Angeles, CA Electronic address
    Radiother Oncol 109:217-21. 2013
    ..The effectiveness of stereotactic body radiotherapy (SBRT) for localized prostate cancer is tested...
  3. doi request reprint Adjuvant versus salvage radiotherapy for high-risk prostate cancer patients
    Christopher R King
    Department of Radiation Oncology, University of California, Los Angeles, CA 90095, USA
    Semin Radiat Oncol 23:215-21. 2013
    ..The evidence regarding the role of androgen deprivation therapy and the use of elective pelvic nodal RT is weak, and ongoing randomized trials are underway. Several clinical scenarios are presented for discussion...
  4. doi request reprint The timing of salvage radiotherapy after radical prostatectomy: a systematic review
    Christopher R King
    Department of Radiation Oncology, UCLA School of Medicine, Los Angeles, California 90095, USA
    Int J Radiat Oncol Biol Phys 84:104-11. 2012
    ..Defining the optimal patient and treatment factors is essential and is particularly relevant within the context of adjuvant vs early vs delayed postoperative radiotherapy (RT)...
  5. doi request reprint Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer
    Christopher R King
    Departments of Radiation Oncology, University of California Los Angeles School of Medicine, Los Angeles, CA 90095, USA
    Int J Radiat Oncol Biol Phys 82:877-82. 2012
    ..The results of a prospective trial of stereotactic body radiotherapy (SBRT) for prostate cancer with long-term patient-reported toxicity and tumor control rates are presented...
  6. pmc Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes
    Debra E Freeman
    Naples Radiation Oncology, PA, USA
    Radiat Oncol 6:3. 2011
    ..Hypofractionated, stereotactic body radiotherapy (SBRT) is an emerging treatment approach for prostate cancer. We present the outcomes for low-risk prostate cancer patients with a median follow-up of 5 years after SBRT...
  7. ncbi request reprint Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database
    Christopher R King
    Division of Urologic Oncology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305 5847, USA
    Urology 69:921-6. 2007
    ....
  8. ncbi request reprint Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial
    Christopher R King
    Department of Radiation Oncology, Division of Urologic Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 73:1043-8. 2009
    ..The radiobiology of prostate cancer favors a hypofractionated dose regimen. We report results of a prospective Phase II clinical trial of stereotactic body radiotherapy (SBRT) for localized prostate cancer...
  9. ncbi request reprint Obesity and risk of biochemical failure for patients receiving salvage radiotherapy after prostatectomy
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305 5847, USA
    Int J Radiat Oncol Biol Phys 73:1017-22. 2009
    ..Using body mass index (BMI) as a measure of obesity, we tested its role as a risk factor for patients receiving salvage RT after prostatectomy...
  10. doi request reprint Prognostic significance of prostate cancer originating from the transition zone
    Christopher R King
    Department of Radiation Oncology, Division of Urologic Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Urol Oncol 27:592-7. 2009
    ..To understand the influence of tumor location, we compared bRFS for TZ and PZ cancers stratified for risk using known clinical and pathological prognostic factors...
  11. ncbi request reprint Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 70:1472-7. 2008
    ..Identification of patients most likely to benefit from salvage radiotherapy (RT) using postoperative (postop) prostate-specific antigen (PSA) kinetics...
  12. doi request reprint Improved outcomes with higher doses for salvage radiotherapy after prostatectomy
    Christopher R King
    Department of Radiation Oncology, Division of Urologic Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 71:23-7. 2008
    ..To evaluate relapse-free survival with higher doses for patients receiving salvage radiotherapy (RT) after radical prostatectomy (RP)...
  13. ncbi request reprint Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy
    Deep A Patel
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305 5847, USA
    J Clin Oncol 23:6157-62. 2005
    ..We evaluated the relative merit of established preoperative factors, including biopsy indices and preoperative PSAV, for their impact on relapse after RP...
  14. ncbi request reprint Radiotherapy after prostatectomy: improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients
    Michael T Spiotto
    Department of Radiation Oncology, Division of Urologic Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 69:54-61. 2007
    ..To compare the biochemical relapse-free survival (bRFS) among patients receiving whole pelvic radiotherapy (WPRT) vs. prostate bed RT (PBRT) after radical prostatectomy...
  15. ncbi request reprint Investigation of linac-based image-guided hypofractionated prostate radiotherapy
    Todd Pawlicki
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305 5847, USA
    Med Dosim 32:71-9. 2007
    ..During this study, we have also uncovered opportunities for improvement of the on-board imaging hardware/software implementation that would further enhance performance in this regard...
  16. doi request reprint Radiotherapy after prostatectomy: is the evidence for dose escalation out there?
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 71:346-50. 2008
    ..To study the effective doses of radiotherapy (RT) after prostatectomy in search for evidence of a dose-response...
  17. doi request reprint Does hormone therapy exacerbate the adverse effects of radiotherapy in men with prostate cancer? A quality of life study
    Jonathan D Grant
    Department of Radiation Oncology, University of California Los Angeles School of Medicine, Los Angeles, California 90095, USA
    J Urol 185:1674-80. 2011
    ....
  18. doi request reprint Intraoperative radiation therapy for locally advanced and recurrent soft-tissue sarcomas in adults
    Phuoc T Tran
    Department of Radiation Oncology, Stanford Cancer Center, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 72:1146-53. 2008
    ..To analyze the outcomes of and identify prognostic factors for patients treated with surgery and intraoperative radiotherapy (IORT) for locally advanced and recurrent soft-tissue sarcoma in adults from a single institution...
  19. ncbi request reprint Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCH
    Christopher R King
    Department of Radiation Oncology, Division of Urologic Oncology, Stanford University School of Medicine, Stanford, California 94305 5847, USA
    Urology 69:732-7. 2007
    ..We studied the timing, cutoff levels, and method of calculation to better define its usefulness...
  20. doi request reprint Incidental testicular irradiation from prostate IMRT: it all adds up
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford Cancer Center, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 77:484-9. 2010
    ..To identify the technical aspects of image-guided intensity-modulated radiation therapy (IMRT) for localized prostate cancer that could result in a clinically meaningful incidental dose to the testes...
  21. doi request reprint Sexual function after stereotactic body radiotherapy for prostate cancer: results of a prospective clinical trial
    Ellen A Wiegner
    Department of Radiation Oncology, Stanford University School of Medicine, CA, USA
    Int J Radiat Oncol Biol Phys 78:442-8. 2010
    ..To study the sexual quality of life for prostate cancer patients after stereotactic body radiotherapy (SBRT)...
  22. ncbi request reprint Reliability of small amounts of cancer in prostate biopsies to reveal pathologic grade
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305 5847, USA
    Urology 67:1229-34. 2006
    ..Prostate biopsy findings are known to undergrade prostate cancer compared with the pathologic specimens yet remain the only grade guiding disease management...
  23. ncbi request reprint A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes
    Annie Hsu
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305 5847, USA
    Int J Radiat Oncol Biol Phys 68:898-902. 2007
    ..To study the impact on nodal coverage and dose to fixed organs at risk when using daily fiducial localization of the prostate to deliver intensity-modulated radiotherapy (IMRT)...
  24. doi request reprint A new formula for normal tissue complication probability (NTCP) as a function of equivalent uniform dose (EUD)
    Gary Luxton
    Department of Radiation Oncology, Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA 94305, USA
    Phys Med Biol 53:23-36. 2008
    ..The inverse equation expresses EUD as a function of NTCP and is used to generate a table of EUD versus normal tissue complication probability for the Emami-Burman parameter fits as well as for OAR parameter sets from more recent data...
  25. ncbi request reprint Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes?
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 59:341-7. 2004
    ....
  26. pmc Intrafractional motion of the prostate during hypofractionated radiotherapy
    Yaoqin Xie
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305 5847, USA
    Int J Radiat Oncol Biol Phys 72:236-46. 2008
    ..To report the characteristics of prostate motion as tracked by the stereoscopic X-ray images of the implanted fiducials during hypofractionated radiotherapy with CyberKnife...
  27. ncbi request reprint CyberKnife radiotherapy for localized prostate cancer: rationale and technical feasibility
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA
    Technol Cancer Res Treat 2:25-30. 2003
    ..These capabilities are essential if one contemplates hypo-fractionated regimens with large dose-per-fraction sizes (>5Gy to 10Gy) and dose-escalation...
  28. ncbi request reprint Prostate biopsy volume indices do not predict for significant Gleason upgrading
    Christopher R King
    Division of Urologic Oncology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305, USA
    Am J Clin Oncol 28:125-9. 2005
    ..This suggests that the correlation that exists between such volume surrogates and outcomes after surgery reflect tumor volume effects only, independently of any possible association between tumor volume and Gleason grade...
  29. ncbi request reprint LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Brachytherapy 1:219-26. 2002
    ....
  30. doi request reprint Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: A pooled analysis of biological equivalent dose and local control
    Niraj Mehta
    Department of Radiation Oncology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California
    Pract Radiat Oncol 2:288-95. 2012
    ..To determine the relationship between tumor control probability (TCP) and biological effective dose (BED) for radiation therapy in medically inoperable stage I non-small cell lung cancer (NSCLC)...
  31. doi request reprint MR spectroscopic imaging and diffusion-weighted imaging of prostate cancer with Gleason scores
    Rajakumar Nagarajan
    Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave, Los Angeles, CA 90095 1721, USA
    J Magn Reson Imaging 36:697-703. 2012
    ..To investigate functional changes in prostate cancer patients with three pathologically proven different Gleason scores (GS) (3+3, 3+4, and 4+3) using magnetic resonance spectroscopic imaging (MRSI) and diffusion-weighted imaging (DWI)...